Shortly after the Supreme Court ruled in favor of the government in King v. Burwell, President Barack Obama triumphantly claimed that "Affordable Care Act is here to stay." However, the truth is that GOP presidential hopefuls have no intention of letting the law stand.
Shortly after the Supreme Court ruled in favor of the government in King v. Burwell, President Barack Obama triumphantly claimed that “Affordable Care Act is here to stay.” However, the truth is that GOP presidential hopefuls have no intention of letting the law stand.
Although both legal challenges to the president’s health law has resulted in the Court upholding big parts of the legislation, opponents to the Affordable Care Act (ACA) are looking to the 2016 presidential election as a way to stop Obamacare and replace it.
“I disagree with the Court’s ruling and believe they have once again erred in trying to correct the mistakes made by President Obama and Congress in forcing Obamacare on the American people,” Sen. Marco Rubio, one of the 2016 presidential hopefuls, said in a statement.
He would like to replace the law with his consumer-centered plan. Other hopefuls are a little more vague on what they would do if elected president. For instance, Jeb Bush has vowed to work with Congress to repeal and replace the law, but has neglected to outline with what.
Sen. Ted Cruz spoke on the Senate floor the day of the Supreme Court’s ruling and made it clear that repealing the ACA was one of his top goals if he was elected president.
“I remain fully committed to repealing every single word of Obamacare,” he said. “And mark my words, following the election in 2016, the referendum that we will have, in 2017 this chamber will return and we will repeal every word of Obamacare.”
However, by the time the 2016 election rolls around, the country will be gearing up for the fourth open enrollment period. Having 3 full years of tens of millions of people enrolled in ACA-sponsored plans could make it more difficult to take insurance away, Avik Roy, senior fellow at the Manhattan Institute, explained.
He believes that the last real chance for Republicans to repeal the ACA was the 2012 election.
“If you just repeal Obamacare for everybody and throw those 20 million people into chaos without certainty as to what they will actually get, I think that’s problematic,” he said in an interview with The American Journal of Managed Care.
“But that isn’t to say you cannot make significant changes to the law,” he added.
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Real-World Study Reveals Key Insights Into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More